Get started
FRESENIUS SE+CO.KGAAFRESENIUS SE+CO.KGAAFRESENIUS SE+CO.KGAA

FRESENIUS SE+CO.KGAA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

FRE chart


Full chart

FRE upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪18.57 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.68 EUR
Net income (FY)
‪−594.00 M‬ EUR
Revenue (FY)
‪22.30 B‬ EUR
Shares float
‪411.09 M‬
Beta (1Y)
0.34

Employees


Employees (FY)
‪193.87 K‬
Change (1Y)
‪+4.99 K‬ +2.64%
Revenue / Employee (1Y)
‪126.96 K‬ EUR
Net income / Employee (1Y)
‪2.01 K‬ EUR

About FRESENIUS SE+CO.KGAA O.N.


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael Sen
Website
fresenius.de
Headquarters
Bad Homburg
Founded
2011
ISIN
DE0005785604
FIGI
BBG00GY18BS1
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

FRE news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

FRE highest yielding bonds


XS223744796
FRESENIUS SE MTN 20/33
Yield to maturity
3.61%
Maturity date
Jan 28, 2033
F
XS232556269
FRES.FIN.IRE 21/31 MTN
Yield to maturity
3.60%
Maturity date
Oct 1, 2031
F
XS155437383
FRESEN.FIN.IRE. 17/32 MTN
Yield to maturity
3.33%
Maturity date
Jan 30, 2032
A3515F
FRESENIUS SE & CO. KGAA 2023-05.10.30
Yield to maturity
3.20%
Maturity date
Oct 5, 2030
XS248287225
FRESENIUS SE MTN 22/30
Yield to maturity
3.12%
Maturity date
May 24, 2030
XS255950142
FRESENIUS SE MTN 22/29
Yield to maturity
3.11%
Maturity date
Nov 28, 2029
FREB
FRESENIUS SE MTN 19/25
Yield to maturity
3.09%
Maturity date
Feb 15, 2025
F
XS232556510
FRES.FIN.IRE 21/28 MTN
Yield to maturity
3.09%
Maturity date
Oct 1, 2028
XS248287241
FRESENIUS SE MTN 22/25
Yield to maturity
3.05%
Maturity date
May 24, 2025
XS255958054
FRESENIUS SE MTN 22/26
Yield to maturity
2.85%
Maturity date
May 28, 2026
F
XS232556242
FRES.FIN.IRE 21/25 MTN
Yield to maturity
2.77%
Maturity date
Oct 1, 2025

Explore more bonds 

Frequently Asked Questions


The current price of FRE is 33.33 EUR — it has increased by 1.74% in the past 24 hours. Watch FRESENIUS SE+CO.KGAA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange FRESENIUS SE+CO.KGAA stocks are traded under the ticker FRE.
FRE stock has risen by 1.28% compared to the previous week, the month change is a −0.89% fall, over the last year FRESENIUS SE+CO.KGAA has showed a 20.50% increase.
We've gathered analysts' opinions on FRESENIUS SE+CO.KGAA future price: according to them, FRE price has a max estimate of 44.00 EUR and a min estimate of 30.00 EUR. Watch FRE chart and read a more detailed FRESENIUS SE+CO.KGAA stock forecast: see what analysts think of FRESENIUS SE+CO.KGAA and suggest that you do with its stocks.
FRE reached its all-time high on Jun 19, 2017 with the price of 79.70 EUR, and its all-time low was 20.00 EUR and was reached on Oct 13, 2022. View more price dynamics on FRE chart.
See other stocks reaching their highest and lowest prices.
FRE stock is 1.74% volatile and has beta coefficient of 0.34. Track FRESENIUS SE+CO.KGAA stock price on the chart and check out the list of the most volatile stocks — is FRESENIUS SE+CO.KGAA there?
Today FRESENIUS SE+CO.KGAA has the market capitalization of ‪18.76 B‬, it has decreased by −1.71% over the last week.
Yes, you can track FRESENIUS SE+CO.KGAA financials in yearly and quarterly reports right on TradingView.
FRESENIUS SE+CO.KGAA is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
FRE earnings for the last quarter are 0.69 EUR per share, whereas the estimation was 0.65 EUR resulting in a 5.54% surprise. The estimated earnings for the next quarter are 0.78 EUR per share. See more details about FRESENIUS SE+CO.KGAA earnings.
FRESENIUS SE+CO.KGAA revenue for the last quarter amounts to ‪5.30 B‬ EUR, despite the estimated figure of ‪5.21 B‬ EUR. In the next quarter, revenue is expected to reach ‪5.42 B‬ EUR.
FRE net income for the last quarter is ‪326.00 M‬ EUR, while the quarter before that showed ‪−373.00 M‬ EUR of net income which accounts for 187.40% change. Track more FRESENIUS SE+CO.KGAA financial stats to get the full picture.
Yes, FRE dividends are paid annually. The last dividend per share was 0.92 EUR. As of today, Dividend Yield (TTM)% is 2.76%. Tracking FRESENIUS SE+CO.KGAA dividends might help you take more informed decisions.
As of Nov 24, 2024, the company has ‪193.87 K‬ employees. See our rating of the largest employees — is FRESENIUS SE+CO.KGAA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESENIUS SE+CO.KGAA EBITDA is ‪2.99 B‬ EUR, and current EBITDA margin is 12.44%. See more stats in FRESENIUS SE+CO.KGAA financial statements.
Like other stocks, FRE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESENIUS SE+CO.KGAA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESENIUS SE+CO.KGAA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESENIUS SE+CO.KGAA stock shows the buy signal. See more of FRESENIUS SE+CO.KGAA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.